| Literature DB >> 35216150 |
Irina V Tyshkunova1, Daria N Poshina1, Yury A Skorik1.
Abstract
The availability, biocompatibility, non-toxicity, and ease of chemical modification make cellulose a promising natural polymer for the production of biomedical materials. Cryogelation is a relatively new and straightforward technique for producing porous light and super-macroporous cellulose materials. The production stages include dissolution of cellulose in an appropriate solvent, regeneration (coagulation) from the solution, removal of the excessive solvent, and then freezing. Subsequent freeze-drying preserves the micro- and nanostructures of the material formed during the regeneration and freezing steps. Various factors can affect the structure and properties of cellulose cryogels, including the cellulose origin, the dissolution parameters, the solvent type, and the temperature and rate of freezing, as well as the inclusion of different fillers. Adjustment of these parameters can change the morphology and properties of cellulose cryogels to impart the desired characteristics. This review discusses the structure of cellulose and its properties as a biomaterial, the strategies for cellulose dissolution, and the factors affecting the structure and properties of the formed cryogels. We focus on the advantages of the freeze-drying process, highlighting recent studies on the production and application of cellulose cryogels in biomedicine and the main cryogel quality characteristics. Finally, conclusions and prospects are presented regarding the application of cellulose cryogels in wound healing, in the regeneration of various tissues (e.g., damaged cartilage, bone tissue, and nerves), and in controlled-release drug delivery.Entities:
Keywords: cellulose; cellulose cryogel; freeze-drying; regenerative medicine; tissue engineering
Mesh:
Substances:
Year: 2022 PMID: 35216150 PMCID: PMC8880007 DOI: 10.3390/ijms23042037
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Ways to produce cellulose cryogel for biomedical applications: (a) via dissolution and regeneration; (b) using nanowhiskers.
Figure 2Complex molecular structure of cellulose: (a) native cellulose I unit cells, triclinic Iα and monoclinic Iβ [37] © 2022 National Academy of Sciences; (b) H-bond network of cellulose I; (c) polymorph transitions.
Characteristics of typical cellulose solvents.
| Solvent | Advantages | Disadvantages | Reference |
|---|---|---|---|
| LiCl/DMAc | It does not cause any destruction of the cellulose, provided that destructive pretreatments are avoided (such as heating over 80 °C). | The difficulty of removing LiCl from the final products. | [ |
| Ionic liquids | They completely dissolve the material’s components. | Ionic liquids do not evaporate, have low volatility, which complicates their regeneration. | [ |
| 7–9%NaOH/water | Cellulose gels can be obtained. | The thermodynamic quality of the solvent decreases with increasing temperature, as the number of cellulose–cellulose interactions increases more rapidly than the number of cellulose–solvent interactions; Na+ ions penetrate deeply into the cellulose structure, making it difficult to remove alkali. | [ |
| Complexing compounds of Cu with ethylenediamine (or Cd-ethylenediamine complexes) | Commonly used to determine the molecular weight of cellulose. | The difficulty of removing from the final products. | [ |
| Direct solvent of cellulose: | In theory, this dissolution process is merely physical, but in practice many side reactions might occur. | [ | |
| Concentrated phosphoric acid | Rapid dissolution, easily removed and regenerated. | Causes significant destruction of macromolecules. | [ |
Figure 3Influence of different factors on cellulose cryogel properties.
Cellulose cryogels for biomedical applications.
| Polymer | Production | Characteristics | Application | Reference |
|---|---|---|---|---|
| MCC | Calcium thiocyanate tetrahydrate and water (117 °C) | Porosity 94.3% | New filter types, various biomedical applications. | [ |
| MCC | 8 wt% NaOH-water (cross-linking with epichlorohydrin) | Pore size up to 200 µm | Drug release, materials with controlled morphology and porosity. | [ |
| MCC/pectin | 1-Allyl-3-methylimidazolium chloride | Dense network structure | Hemostatic material (had no effect on cell proliferation but offered favorable properties in liver hemostasis). | [ |
| HEC | Cryogenic treatment with citric acid, freeze-drying | Interconnected pores 100–180 µm | Matrices for immobilized enzymes and cells, readily degraded in acidic conditions | [ |
| HEC/polyaniline | Stirred at 40 °C in water for 20 min, sonicated | tissue engineering scaffolds, high survival and proliferation in electric field, good adhesion, spreading, and rearrangement onto materials. | [ | |
| CMC | Dissolved in deionized water and crosslinking with adipic acid dihydrazide and a small excess of the carbodiimide at −20 °C. | E 4.2 ± 1.4 MPa | Neural tissue engineering, cell delivery (restoration of brain tissue through delivery to the neural network). | [ |
| CMC/Col | Mixing two streams: CMC solution (2%) in deionized water with adipic acid dihydrazide, buffer solution and solution N-(3-dimethylaminopopyl)-N′-ethylcarbodiimide chloridate (EDC, in deionized water). The resulting cryogels were soaked in the collagen solution, and then soaked in the EDC solution to fix the collagen. | Porosity > 90% | Tissue engineering, spreading and proliferation of NOR-10 fibroblasts. | [ |
| CMC/Col | Mixing two solutions (1:2)-CMC solution (distilled water), Col solution (acetic acid). | Average lamellar spaces 204 ± 95 µm (Col/CMC) and 195 ± 21 µm (Col/CMC/TCP) | Regeneration of hard tissues, non-toxic and compatible with blood. | [ |
| CMC/PVA/honey | Solvent water, each layer was applied alternately with preliminary freezing of the previous. | Wound healing, showed activity against | [ | |
| CNF | Mechanical defibrillation in deionized water, sonication to obtain the nanofibril aqueous gel, which then sprayed and atomized at 40 MPa, frozen in liquid nitrogen and freeze-dried. | Density 0.0018 g/cm3 | Tissue engineering, evaluated using 3T3 NIH cells. | [ |
| CNF | Solvent-TEMPO, sodium bromide, NaOH. | Porosity 88.0–99.7% | Tissue engineering, evaluated using HeLa and Jurkat cells. | [ |
| CNF | CNF powder in deionized water dispersed by sonication, crosslinked with glyoxal solutions, frozen in liquid nitrogen, freeze-dried. | For CNF cryogel 35 ± 9 µm, for crosslinked cryogel 60 ± 20 µm | Bone tissue engineering, assayed in vitro with MG-63 cells. | [ |
| CNF/Col | NCFs were sonicated, oxidized by NaIO4. The dialdehyde NCFs were mixed with collagen 1:1, frozen and freeze-dried. | Porosity 90–95% | Tissue engineering, supported fibroblast proliferation. | [ |
| CNF/gelatin/chitosan | Crosslinking in situ with genipin, frozen and freeze-dried. | Porosity 95% | Cartilage tissue engineering (ASC and L929 cells) | [ |
| CNF/ bioactive glass | Cellulose nanofibrils (CNF) are introduced. | High porosity | Bone tissue engineering (MC3T3-E1 cells and calvarial bone defect in rats in vivo) | [ |
| CNF/PVA | Crosslinking with polyamide-epichlorohydrin, frozen in liquid nitrogen, freeze-dried. | Porosity 88.5–95.3%Pore size 90 and 20 µm | Skin tissue engineering, supported fibroblast cells. | [ |
| CNF)/ | Crosslinked and sonicated, frozen in liquid nitrogen, freeze-dried. | Density 0.01–0.14 g/m3 | Drug release. | [ |
| Cellulose (wood dust from the plywood sanding) | Nanocellulose suspension from alkaline treated wood waste powders was redispersed in deionized water, frozen and freeze-dried. | Porosity 97.8–99.8% | Biomedicine, pollution filtering, thermal insulation. | [ |
MCC—microcrystalline cellulose, ECH—epichlorohydrin, HEC—hydroxyethylcellulose, CMC—carboxymethyl cellulose, ECM—extracellular matrix, EDC—N-(3-dimethylaminopopyl)-N′-ethylcarbodiimide chloridate, Col—collagen, TCP—tricalcium phosphate, TEMPO—2,2,6,6-tetramethylpiperidin-1-yl oxyl, PVA—polyvinyl alcohol, CNF—cellulose nanofibril, NIPAm—N-isopropylacrylamide.